Cytokinetics Stock Price on November 29, 2024
| CYTK Stock | USD 52.22 0.20 0.38% |
Below is the normalized historical share price chart for Cytokinetics extending back to April 29, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cytokinetics stands at 52.22, as last reported on the 29th of November, with the highest price reaching 52.84 and the lowest price hitting 51.66 during the day.
If you're considering investing in Cytokinetics Stock, it is important to understand the factors that can impact its price. Cytokinetics secures Sharpe Ratio (or Efficiency) of -0.0156, which signifies that the company had a -0.0156% return per unit of risk over the last 3 months. Cytokinetics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytokinetics' Mean Deviation of 1.93, standard deviation of 2.53, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide.
At this time, Cytokinetics' Stock Based Compensation To Revenue is quite stable compared to the past year. . At this time, Cytokinetics' Price To Sales Ratio is quite stable compared to the past year. Price Sales Ratio is expected to rise to 1,124 this year, although the value of Price Earnings Ratio is projected to rise to (14.55). Cytokinetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 2004 | 200 Day MA 58.9894 | 50 Day MA 53.3126 | Beta 0.783 |
Cytokinetics |
Sharpe Ratio = -0.0156
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CYTK |
Estimated Market Risk
| 2.49 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cytokinetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cytokinetics by adding Cytokinetics to a well-diversified portfolio.
Price Book 60.3093 | Enterprise Value Ebitda (15.82) | Price Sales 1.9 K | Shares Float 117.4 M | Wall Street Target Price 81.4118 |
Cytokinetics Valuation on November 29, 2024
It is possible to determine the worth of Cytokinetics on a given historical date. On November 29, 2024 Cytokinetics was worth 52.03 at the beginning of the trading date compared to the closed value of 52.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cytokinetics stock. Still, in general, we apply an absolute valuation method to find Cytokinetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cytokinetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cytokinetics' related companies.
| Open | High | Low | Close | Volume | |
| 52.03 | 52.84 | 51.66 | 52.22 | 792,656 | |
11/29/2024 | 52.03 | 52.84 | 51.66 | 52.22 | 0.00 |
| Backtest Cytokinetics | | | Cytokinetics History | | | Cytokinetics Valuation | Previous |
Cytokinetics Trading Date Momentum on November 29, 2024
| On November 29 2024 Cytokinetics was traded for 52.22 at the closing time. The top price for the day was 52.84 and the lowest listed price was 51.66 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.36% . |
Cytokinetics Fundamentals Correlations and Trends
By evaluating Cytokinetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cytokinetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cytokinetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cytokinetics Stock history
Cytokinetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cytokinetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cytokinetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cytokinetics stock prices may prove useful in developing a viable investing in Cytokinetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 96.5 M | 101.4 M | |
| Net Loss | -350.1 M | -332.6 M |
Cytokinetics Quarterly Net Working Capital |
|
Cytokinetics Stock Technical Analysis
Cytokinetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cytokinetics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Cytokinetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cytokinetics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns
Cytokinetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cytokinetics' price direction in advance. Along with the technical and fundamental analysis of Cytokinetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cytokinetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytokinetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.38) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.225 | Return On Assets (0.30) | Return On Equity (5.72) |
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytokinetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.